Apimeds Pharmaceuticals US, Inc. (APUS) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$8.93M | -1116.8% |
| 2024 | -$733.5K | -16.8% |
| 2023 | -$627.8K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$8.93M | -1116.8% |
| 2024 | -$733.5K | -16.8% |
| 2023 | -$627.8K | — |